InspireMD, Inc. — Director's Dealing 2015

Mar 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2015-03-09

Reporting Person: Stuka Paul (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-09	Common Stock	P	625000	—	Acquired	1370204	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-09	Warrants (right to buy)	$0.55	P	625000	Acquired	2020-03-09	Common Stock (625000)	Indirect

Footnotes

F1: In connection with the public offering, on March 9, 2015 (the "Offering"), the reporting person purchased 625,000 shares of common stock and warrants to purchase 625,000 shares of common stock.

F2: The purchase price for the reported securities was $0.40 per share of common stock and accompanying warrant to purchase one share of common stock, which were purchased together in the Offering.

F3: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). Mr. Stuka serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, Mr. Stuka may be deemed to beneficially own the reported securities. Mr. Stuka disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes.